©2021 Zhejiang Zhebei Pharmaceutical Co., Ltd. All rights reserved
请拖入内容到容器
ABOUT US
Zhejiang zhebei pharmaceutical co., ltd
The predecessor of Zhejiang Zhebei Pharmaceutical Co., Ltd.was Zhebei Pharmaceutical Factory, which was established in 1989.It is a professional pharmaceutical factory that produces nucleoside antiviraland cardiovascular drugs. It is a key medium-sized high-tech enterpriseof theZhejiang’s pharmaceutical industry. The companyhas aregistered capital of 50 million yuan, and its subsidiaries include Zhejiang Zhongcheng Pharmaceutical Co., Ltd., Zhejiang Haojie Pharmaceutical Technology Co., Ltd.,
请拖入内容到容器
PRODUCTS
The main products are sodium fructose diphosphate oral solution, inosine oral solution, Weilinein (ribavirin tablets), Weidimin (cetirizine hydrochloride tablets), acyclovir tablets, inosine tablets, metformin tablets Liebenurea tablets, sodium fructose diphosphate for injection and more than 20 kinds of pharmaceutical preparations.
请拖入内容到容器
NEWS
The raw materials mainly include cetirizine hydrochloride, acyclovir, ribavirin, aminobutyric acid, etc.; the preparations meet the domestic market, and the raw materials are exported to all over the world.
"Drug separation" under the background of drug sales ushered in the structure.
Zhejiang Zhejiang north pharmaceutical Co., Ltd., formerly known as the North Zhejiang Pharmaceutical Factory, was founded in 1989. Is a production of nucleoside antiviral and cardiovascular drugs.
Pharmaceutical industry investment report: medical index adjustment.
According to the changes in population structure and the savings rate of the residents, according to the life cycle income, the young and young people are the producers and savers of the society, while the elderly and the children are the main consumers, the proportion of the producers / consumers in China is top in 2015, and the year of -2050 in 2020 is the high speed and old age of China, and the average annual increase of the population is 6 million 200 thousand. By 2030, the number of people over the age of 65 will reach 300 million. The health resources consumed by the elderly are 1.9 times the total consumption of health resources by the whole population.
The new deal in the Hangzhou bio pharmaceutical industry was implemented on 20 days
By analyzing the factors that drive the growth of the pharmaceutical industry, we find that the increase in disposable income, the aging of the population, the increase of government investment, and the promotion of health awareness are constantly strengthening and long-term existence, especially the increase of disposable income and the aging of the population are the most important factors.
Warmly celebrate the official line of the official website of the pharmaceutical industry in Northern Zhejiang Province.
Warmly celebrate the official line of the official website of the pharmaceutical industry in Northern Zhejiang Province.
请拖入内容到容器
CONTACT US
Zhejiang zhebei pharmaceutical co., ltd
请拖入内容到容器
